Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Anatomy
|
June 17, 2004
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
Claudio Scavelli, Elisabetta Weber, Margherita Aglianò, et al.
Current Drug Targets. Inflammation and Allergy
|
February 22, 2005
Antiangiogenesis for rheumatoid arthritis
Aldo M Roccaro, Francesca Russo, Teresa Cirulli, et al.
Clinical and Experimental Medicine
|
September 16, 2008
Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas
Roberto Ria, Teresa Cirulli, Teresa Giannini, et al.
British Journal of Haematology
|
April 9, 2005
Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells
Antonio Pellegrino, Roberto Ria, Giulia Di Pietro, et al.
Thrombosis and Haemostasis
|
December 8, 2004
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma
Roberto Ria, Angelo Vacca, Francesca Russo, et al.
Cancer Letters
|
October 27, 2004
Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy
Roberto Ria, Maurizio Portaluri, Francesca Russo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma
Roberto Ria, Claudia Piccoli, Teresa Cirulli, et al.
Blood
|
May 11, 2006
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma
Angelo Vacca, Claudio Scavelli, Guido Serini, et al.
Molecular Cancer Therapeutics
|
December 20, 2007
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma
Claudio Scavelli, Giulia Di Pietro, Teresa Cirulli, et al.
Blood
|
June 6, 2008
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Anatomy
|
June 17, 2004
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
Claudio Scavelli, Elisabetta Weber, Margherita Aglianò, et al.
Current Drug Targets. Inflammation and Allergy
|
February 22, 2005
Antiangiogenesis for rheumatoid arthritis
Aldo M Roccaro, Francesca Russo, Teresa Cirulli, et al.
Clinical and Experimental Medicine
|
September 16, 2008
Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas
Roberto Ria, Teresa Cirulli, Teresa Giannini, et al.
British Journal of Haematology
|
April 9, 2005
Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells
Antonio Pellegrino, Roberto Ria, Giulia Di Pietro, et al.
Thrombosis and Haemostasis
|
December 8, 2004
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma
Roberto Ria, Angelo Vacca, Francesca Russo, et al.
Cancer Letters
|
October 27, 2004
Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy
Roberto Ria, Maurizio Portaluri, Francesca Russo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma
Roberto Ria, Claudia Piccoli, Teresa Cirulli, et al.
Blood
|
May 11, 2006
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma
Angelo Vacca, Claudio Scavelli, Guido Serini, et al.
Molecular Cancer Therapeutics
|
December 20, 2007
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma
Claudio Scavelli, Giulia Di Pietro, Teresa Cirulli, et al.
Blood
|
June 6, 2008
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, et al.
Page
of 1